The summit brought together global leaders to reframe advocacy as the engine of patient-centred change, proving that connected voices can drive collective impact ...

The rebranding of Uniphar’s US divisions aims to strengthen its integrated platform across the product life cycle ...

Could it be,” he asked, “that creativity needs slack and while some companies have allowed for this, others haven’t, and this is reflected in the creativity of their customer experience approaches?” I ...

Even with those alarming numbers, the US FDA approvals of disease-modifying therapies (DMTs) such as Leqembi (lecanemab) and ...

Metro maps in unfamiliar cities offer a complex, often – confusing, matrix of opportunities with their twisting lines, but ...

Novartis has reported new results from two ongoing phase 3 trials evaluating ianalumab in patients with Sjögren’s disease, ...

Kyowa Kirin, the European subsidiary of the Japan-based specialty pharmaceutical company, and University Hospitals Birmingham ...

The expansion forms part of Lilly’s broader $50bn capital investment programme to grow its US manufacturing and production ...

UCB, a global biopharmaceutical company, has announced the final results from its open-label extension (OLE) study evaluating ...

Medherant, a clinical-stage company developing treatments using a novel transdermal drug delivery technology, has reported ...

Aqilion, a Swedish biopharma company developing therapies for diseases driven by chronic inflammation and dysregulated immune ...

Medicus Pharma, a biotech and life sciences company developing novel and disruptive therapeutics, has announced the enrolment ...